Third-Party Satellite Facilities – Mitigating CDMO Risks
Introduction In the fast-evolving landscape of pharmaceutical manufacturing, Contract Development and Manufacturing Organizations (CDMOs) have become essential partners for drug companies, providing outsourced services from drug development to full-scale production. However, relying solely on CDMOs comes with inherent risks, such as supply chain disruptions, capacity constraints, and quality control issues, which can compromise the timely […]